Equillium Inc
Equillium Inc (EQ) Option Chain
As of September 17, 2026, Equillium Inc is trading at $1.94, a +2.65% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 0.0%. IV Rank is 1%.
Read more
Tracking the EQ option chain helps you see every strike and expiry on Equillium Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Equillium Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of EQ options activity at a glance. Use our scanner to monitor the EQ option chain in real time and filter for the EQ options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For EQ stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the EQ option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where EQ stock options are being actively traded and where they are not.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases.
The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Equillium Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen EQ options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of EQ stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile1.19% Subdued
- Market cap (M$)120
- 52 weeks high-46.61%
- 52 weeks low148.68%
- Analyst recommendationStrong Buy
1.00 - Target price$8.60
343.30% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-0.20
- EPS growth next 5 years11.40%
As of September 17, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 100.00 | 1,370 | 0 | 0.05 | 0.00 | — | 0.05 | 2.50 | +32.28 | — | 1.60 | 0.56 | 1.04 | 0 | 14 | 0.00 |
| 100.00 | 0 | 0 | 1.55 | 0.00 | — | 1.55 | 5.00 | +164.55 | 2.10 | 4.10 | 3.06 | 0.04 | 0 | 0 | 0.00 |
| 100.00 | 0 | 0 | 1.55 | 0.00 | — | 1.55 | 7.50 | +296.83 | 4.60 | 6.60 | 5.56 | 0.04 | 0 | 0 | 0.00 |
As of September 17, 2026
Scan the full option chain in one place
Browse the full EQ option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→